Explore recent issues of Contract Pharma covering key industry trends.
Read the full digital version of our magazine online.
Stay informed! Subscribe to Contract Pharma for industry news and analysis.
Get the latest updates and breaking news from the pharmaceutical and biopharmaceutical industry.
Discover the newest partnerships and collaborations within the pharma sector.
Keep track of key executive moves and promotions in the pharma and biopharma industry.
Updates on the latest clinical trials and regulatory filings.
Stay informed with the latest financial reports and updates in the pharma industry.
Expert Q&A sessions addressing crucial topics in the pharmaceutical and biopharmaceutical world.
In-depth articles and features covering critical industry developments.
Access exclusive industry insights, interviews, and in-depth analysis.
Insights and analysis from industry experts on current pharma issues.
A detailed look at the leading US players in the global pharmaceutical and BioPharmaceutical industry.
Browse companies involved in pharmaceutical manufacturing and services.
Comprehensive company profiles featuring overviews, key statistics, services, and contact details.
A comprehensive glossary of terms used in the pharmaceutical and biopharmaceutical industry.
Watch in-depth videos featuring industry insights and developments.
Listen to expert discussions and interviews in pharma and biopharma.
Download in-depth eBooks covering various aspects of the pharma industry.
Access detailed whitepapers offering analysis on industry topics.
View and download brochures from companies in the pharmaceutical sector.
Explore content sponsored by industry leaders, providing valuable insights.
Stay updated with the latest press releases from pharma and biopharma companies.
Explore top companies showcasing innovative pharma solutions.
Meet the leaders driving innovation and collaboration.
Engage with sessions and panels on pharma’s key trends.
Hear from experts shaping the pharmaceutical industry.
Join online webinars discussing critical industry topics and trends.
A comprehensive calendar of key industry events around the globe.
Live coverage and updates from major pharma and biopharma shows.
Find advertising opportunities to reach your target audience with Contract Pharma.
Review the editorial standards and guidelines for content published on our site.
Understand how Contract Pharma handles your personal data.
View the terms and conditions for using the Contract Pharma website.
What are you searching for?
Chris Rombach brings 30+ years of experience in leadership and sales management within the biopharmaceutical sector to the role.
February 18, 2025
By: Charlie Sternberg
Asahi Kasei Bioprocess America Inc. (AKBA), a provider of advanced filtration and fluid management solutions for the biopharmaceutical industry, has appointed Chris Rombach as its President.
Rombach, who previously served as Executive Vice President and Head of Fluid Management, brings over 30 years of experience in leadership and sales management within the biopharmaceutical sector.
Throughout his career, he has contributed to advancing bioprocessing systems, including serving as a founding member of the Bio-Process Systems Alliance (BPSA) and pioneering the adoption of single-use systems. Since joining the company five years ago, Rombach has led commercial growth functions. While many companies focused on solutions related to the COVID-19 pandemic, Rombach elected to pursue the Oligosynthesis market to establish AKBA as a key player in the process. That work, coupled with a focus on promoting their MOTIV buffer formulation system, helped fuel a strong growth trajectory.
“I am honored and excited to step into the role of President at AKBA,” said Rombach. “Together, we will pursue new challenges, foster ideas for our stakeholders, and drive our vision forward. Most importantly, we will continue to build a brighter future for our team, our community, and, of course, our wonderful customers, creating an experience that is truly ‘Built for You.'”
Under Rombach’s leadership, AKBA aims to strengthen its commitment to delivering forward-thinking solutions that enhance safety and efficiency in biologics manufacturing. The company will continue helping customers solve purity challenges in their development processes. Rombach will also support business entities, including human resources and finance.
“Chris’ deep industry expertise, passion for innovation, and unwavering commitment to our customers make him the ideal leader to take AKBA into the future,” said Yusuke Kanazawa, Head Asahi Kasei’s Bioprocess Division. “We are confident that his vision will drive continued growth and success for our organization and partners.”
Enter your account email.
A verification code was sent to your email, Enter the 6-digit code sent to your mail.
Didn't get the code? Check your spam folder or resend code
Set a new password for signing in and accessing your data.
Your Password has been Updated !